Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study
about
CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virusHCV Coinfection Associated with Slower Disease Progression in HIV-Infected Former Plasma Donors Naïve to ARTA comparison of HAART outcomes between the US military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS)Factors Influencing Uptake of Rapid HIV and Hepatitis C Screening Among Drug Misusing Adult Emergency Department Patients: Implications for Future HIV/HCV Screening Interventions.Combining epidemiologic and biostatistical tools to enhance variable selection in HIV cohort analyses.Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1-positive and HCV-positive patients.Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.Seroprevalence of HCV and its co-infection with HBV and HIV among liver disease patients of South Tamil Nadu.Hepatitis C and the risk of kidney disease and mortality in veterans with HIVEffects of HCV on basal and tat-induced HIV LTR activationActivation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virusComparison of Rates of Death Having any Death-Certificate Mention of Heart, Kidney, or Liver Disease Among Persons Diagnosed with HIV Infection with those in the General US Population, 2009-2011Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort studyThe association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individualsCost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.Impact of hepatitis C on HIV progression in adults with alcohol problemsReframing "prevention with positives": incorporating counseling techniques that improve the health of HIV-positive patients.Treatment of hepatitis C in HIV-coinfected patients.Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected WomenHCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.Hepatitis C Screening in People With Human Immunodeficiency Virus: Lessons Learned From Syphilis ScreeningAcute hepatitis C in an HIV-infected patient: a case report and review of literaturePredictors of Mortality among United States Veterans with Human Immunodeficiency Virus and Hepatitis C Virus Coinfection.Neurocognitive impact of antiretroviral treatment: thinking long-term.Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?Comparison of colorectal cancer screening and diagnoses in HIV-positive and HIV-negative veterans.Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study.Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection.Long-Term Consequences of Hepatitis C Viral Clearance on the CD4 (+) T Cell Lymphocyte Course in HIV/HCV Coinfected Patients.Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection.Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.Survival of HIV-positive individuals with hepatitis B and C infection in Michigan.Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis.HIV-HCV Coinfection.Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients.Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan.
P2860
Q27486398-6A7A26E0-248C-4E2B-8A38-77925BF36890Q27487500-01B70D9F-C77B-4A0F-807C-33E8B5FCA960Q30486127-CD310B05-1F3D-4257-91E3-324F4A7DCB23Q30667479-B16C67FF-5659-4B0E-BF03-393980D59055Q31149210-45F7372E-8F84-4664-A6FB-4E3D0848FD59Q33585762-B53B3B51-F4AA-4E35-AD2D-CC4420AE85ABQ33889960-CAB8BE19-C16F-46EC-97A1-605DC820DC34Q34329530-9DAFF36D-018F-46DE-B1EB-BEAB78D86FBEQ34390184-9F08F25E-47F3-4FEE-8A25-D389DAACCA03Q34546552-1A33147E-2F36-4306-BAB0-2F22551AA41DQ34769530-B38BE953-6B3B-42AF-A1CF-37177B0E7EC8Q35018396-97BD4C30-2B9D-44F4-BE9E-D74649459E37Q35157763-136A914D-8CB8-4BAD-ADCE-863D2DC55466Q35386113-2C011F0A-1C01-4CC4-B0A1-7F97BBEDD893Q35652711-C22A5AC9-333E-42F4-8D41-36E905E3A25CQ36083457-A18EAC5B-0DBA-4910-BC22-54664FB56BA6Q36102868-F22A8E5C-B1CA-46B7-96B0-6C4BF080E878Q36373515-43C71EFB-BF00-4FD2-9755-CEE74FAA1089Q36409500-7A2E731F-7C6F-4781-AED7-7B42723884DEQ36462052-EB7404E8-6094-4CB4-A995-EC07BF888682Q36479368-BAF015DF-F982-44D5-AFC0-32222DBDCAEAQ36505229-67BA901F-0980-4366-9CB0-7D15F93FF953Q36575314-76D8E957-01B7-41A3-9EA2-7927295CE5EAQ36780300-836C0BFB-939E-4AF9-BAAF-FF71945C4B6BQ37731286-2B377072-A734-412E-9310-CC05CE8FF374Q37916327-C4DB2298-AE6D-456A-9786-F563CD10908AQ38460898-669C9030-0546-40E3-8355-23F69C040CF0Q38903274-796F5E24-F581-499E-9CA8-3BA255B63387Q39162257-B862C7D1-38D4-4864-87EE-C8F85EB1839CQ41524630-10BC71DC-F1B9-4ECE-8FBC-1F9F40A3301FQ41706245-6618BD59-586A-4C46-8C91-4F6E50E692BEQ41856139-B5078E6E-A46D-4C0A-AC7B-C780A0B1233DQ42054116-47262812-313A-459C-A06C-2447F3E5D101Q42140762-CBDCBBF5-6028-4BCD-A6B7-44A219F1C325Q42221844-E8296115-6D12-4138-95CB-A92EF634608CQ42252448-054C6B0F-4A77-463C-B26C-DF2ED9378AC0Q42271731-88F41EDE-2ED1-4A86-B799-FA3A0C0F7E2EQ42318165-16134243-4D2C-4A3C-8508-6532E81CA0B1Q44229859-9F1594AD-6AA9-461D-A3CB-E423309F2093Q45266011-AAD3FED0-8B3B-4E07-BD99-DD840B8F5557
P2860
Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@ast
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@en
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@nl
type
label
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@ast
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@en
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@nl
prefLabel
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@ast
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@en
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@nl
P2093
P921
P356
P1476
Hepatitis C virus coinfection ...... he HIV Atlanta VA Cohort Study
@en
P2093
David Rimland
Jodie L Guest
Katie B Anderson
P304
P356
10.1086/425360
P407
P577
2004-11-15T00:00:00Z